Insider · CIK 0002030709
Mark Kawakami
Files at RKDA (Arcadia Biosciences, Inc.). First filing Feb 5, 2025, latest Feb 5, 2025.
Mark Kawakami files SEC Form 4 as CFO at RKDA (Arcadia Biosciences, Inc.). Since Feb 5, 2025, Mark Kawakami has reported 1 open-market buy worth $1,743 and 0 open-market sells worth $0, the latest filed on Feb 5, 2025.
A track record needs three past buys with six months of prices behind them; Mark Kawakami has 0, so none is measured yet.
The newest scored trade: bought $1,743 of RKDA on Feb 3, 2025, filed Feb 5, 2025, scored 36 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RKDA: Arcadia Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Arcadia Biosciences, Inc. | $1,743 700 shares | +35% | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 9, 2025 | RKDA Arcadia Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 33,987 | May 12, 2025 |
| Feb 3, 2025 | RKDA Arcadia Biosciences, Inc. | POpen-market purchase Common Stock | +700 | $2.49 | $1,743 | 2,681 | Feb 5, 2025 |
Questions about Mark Kawakami
Answered from the filings on this page, as of the latest one.
Is Mark Kawakami buying or selling?
Not in the last 12 months. Mark Kawakami's latest open-market trade on SEC Form 4 was bought $1,743 of RKDA on Feb 3, 2025.
How did Mark Kawakami's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Kawakami has 0.
Where does Mark Kawakami file Form 4?
Mark Kawakami has filed Form 4 at RKDA (Arcadia Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.